&Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.4M | Buy |
28,690
+1,814
| +7% | +$871K | 0.06% | 297 |
|
|
2026
Q1 | $13.2M | Buy |
26,876
+2,130
| +9% | +$1.16M | 0.07% | 272 |
|
|
2025
Q4 | $14.3M | Buy |
24,746
+3,301
| +15% | +$1.87M | 0.08% | 244 |
|
|
2025
Q3 | $10.4M | Buy |
21,445
+970
| +5% | +$451K | 0.07% | 255 |
|
|
2025
Q2 | $8.33M | Buy |
20,475
+8,497
| +71% | +$3.55M | 0.06% | 264 |
|
|
2025
Q1 | $5.96M | Buy |
11,978
+10
| +0.1% | +$5.42K | 0.06% | 262 |
|
|
2024
Q4 | $6.36M | Buy |
11,968
+3,323
| +38% | +$1.83M | 0.08% | 240 |
|
|
2024
Q3 | $5.35M | Buy |
8,645
+5,260
| +155% | +$3.11M | 0.1% | 194 |
|
|
2024
Q2 | $1.87M | Buy |
3,385
+2,170
| +179% | +$1.24M | 0.08% | 219 |
|
|
2024
Q1 | $706K | Sell |
1,215
-262
| -18% | -$147K | 0.1% | 210 |
|
|
2023
Q4 | $784K | Buy |
1,477
+642
| +77% | +$311K | 0.19% | 120 |
|
|
2023
Q3 | $423K | Buy |
835
+70
| +9% | +$37.3K | 0.2% | 96 |
|
|
2023
Q2 | $399K | Hold |
765
| – | – | 0.18% | 101 |
|
|
2023
Q1 | $441K | Buy |
765
+27
| +4% | +$15.2K | 0.21% | 93 |
|
|
2022
Q4 | $406K | Sell |
738
-91
| -11% | -$48.2K | 0.2% | 96 |
|
|
2022
Q3 | $420K | Sell |
829
-13
| -2% | -$7.28K | 0.24% | 93 |
|
|
2022
Q2 | $457K | Hold |
842
| – | – | 0.26% | 89 |
|
|
2022
Q1 | $497K | Buy |
842
+29
| +4% | +$16.7K | 0.28% | 88 |
|
|
2021
Q4 | $542K | Hold |
813
| – | – | 0.33% | 74 |
|
|
2021
Q3 | $464K | Hold |
813
| – | – | 0.3% | 81 |
|
|
2021
Q2 | $410K | Buy |
813
+13
| +2% | +$6.13K | 0.27% | 91 |
|
|
2021
Q1 | $365K | Buy |
800
+130
| +19% | +$62K | 0.27% | 91 |
|
|
2020
Q4 | $312K | Sell |
670
-30
| -4% | -$14.1K | 0.26% | 91 |
|
|
2020
Q3 | $309K | Sell |
700
-100
| -13% | -$41.3K | 0.31% | 75 |
|
|
2020
Q2 | $290K | Buy |
800
+84
| +12% | +$28.2K | 0.35% | 76 |
|
|
2020
Q1 | $203K | Sell |
716
-100
| -12% | -$31.5K | 0.32% | 99 |
|
|
2019
Q4 | $265K | Sell |
816
-100
| -11% | -$30.3K | 0.32% | 109 |
|
|
2019
Q3 | $267K | Sell |
916
-90
| -9% | -$25.8K | 0.35% | 104 |
|
|
2019
Q2 | $295K | Sell |
1,006
-140
| -12% | -$38.6K | 0.41% | 82 |
|
|
2019
Q1 | $314K | Buy |
+1,146
| New | +$285K | 0.45% | 78 |
|
Other funds holding TMO
&Partners's TMO Position: Q2 2026 in Review
&Partners increased its Thermo Fisher Scientific (TMO) stake by 6.7% in Q2 2026, buying an estimated $871K and bringing the position to 28,690 shares worth $14.4M. The position accounts for 0.06% of the portfolio, ranked #297.
&Partners first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- &Partners held 28,690 shares of Thermo Fisher Scientific worth $14.4M as of Q2 2026.
- &Partners bought 1,814 Thermo Fisher Scientific shares in Q2 2026, an estimated $871K.
- Thermo Fisher Scientific made up 0.06% of &Partners's portfolio in Q2 2026, its #297 holding.
- &Partners first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.